Balancing Flexibility and Reproducibility in Staining

Discovery Life Sciences

Discovery Life Sciences supports biopharma organizations with biomarker and translational research services spanning molecular pathology, immunohistochemistry, multiplex immunofluorescence, and digital pathology. Discovery also operates one of the industry's largest and extensively characterized biospecimen repositories, giving biopharma partners a single point of access from sample sourcing through downstream biomarker analysis.

As biomarker research expands across new targets, tissue types, and multiplex applications, staining workflows must adapt, balancing protocol flexibility with reproducible performance to generate reliable biomarker data.

In this video, Discovery Life Sciences experts discuss how the BOND RX research stainer supports immunohistochemistry (IHC) and multiplex immunofluorescence (mIF) assay development through configurable protocols, intuitive operation, precise reagent delivery, and standardized staining execution. This flexibility enables the Discovery Life Sciences team to evaluate and optimize assay conditions across diverse studies.

Developing new biomarkers, refining multiplex panels, or working with limited tissue samples, reproducible staining is the foundation for confident downstream image analysis and biomarker evaluation. Hear how Discovery Life Sciences built that foundation with the BOND RX research stainer.

View More Customer Stories here: Customer Testimonials - YouTube

Learn more about Discovery Life Sciences.